British-Swedish drugs giant Astrazeneca, led by boss Pascal Soriot (pictured), is buying the rare diseases specialist as part of plans to expand into new lucrative areas of treatment.
Astrazeneca boss damns critics of £29bn deal to buy Alexion, pledging it will propel company to top of FTSE 100 By Daily Mail City & Finance Reporter Published: 21:50 GMT, 27 December 2020 | Updated: 21:50 GMT, 27 December 2020 Astrazeneca’s chief executive has damned critics of his £29billion deal to buy Alexion, pledging it … Read more
Astrazeneca to take out £13bn bridging loan to finance blockbuster takeover of US giant Alexion Pharmaceuticals By Daily Mail City & Finance Reporter Published: 21:51 GMT, 13 December 2020 | Updated: 21:53 GMT, 13 December 2020 Astrazeneca will take out a £13billion bridging loan to finance its blockbuster takeover of US giant Alexion Pharmaceuticals. The … Read more
British drugs giant AstraZeneca pounces on rival Alexion in deal worth £29.5bn By Neil Craven, Financial Mail on Sunday Published: 21:56 GMT, 12 December 2020 | Updated: 22:43 GMT, 12 December 2020 British drugs giant AstraZeneca will acquire North American rival Alexion Pharmaceuticals in a deal worth $39billion (£29.5billion), it was announced yesterday. The deal … Read more